Gingival Recession and Localized Aggressive Periodontitis Among HIV-infected Children and Adolescents Receiving Antiretroviral Therapy

被引:6
|
作者
Blignaut, Elaine [1 ]
Rossouw, Theresa M. [2 ]
Becker, Piet J. [3 ]
Mavuso, Diana S. [1 ]
Feucht, Ute D. [4 ]
机构
[1] Univ Pretoria, Sch Dent, Dept Oral Pathol & Oral Biol, Pretoria, South Africa
[2] Univ Pretoria, Sch Med, Dept Immunol, Pretoria, South Africa
[3] Univ Pretoria, Res Support Off, Pretoria, South Africa
[4] Univ Pretoria, Sch Med, Fac Hlth Sci, Dept Paediat, Pretoria, South Africa
关键词
HIV infection; children; adolescents; aggressive periodontitis; South Africa;
D O I
10.1097/INF.0000000000002166
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Limited information is available on gingival recession or localized aggressive periodontitis among HIV-infected children and adolescents. This study reports on the prevalence of these conditions among children and adolescents receiving antiretroviral therapy (ART). Methods: A cross-sectional study on HIV-infected children and adolescents attending a Pediatric HIV clinic in Gauteng, South Africa, between January 2013 and June 2016. Patients received an oral examination and oral hygiene instructions, irrespective of oral- or dental-related complaints. Hard and soft tissue pathology was managed and recorded, together with relevant demographic and clinical data. Statistical analysis was performed in Stata 14 with P < 0.05 as significant. Results: A total of 554 children and adolescents 5-19 years of age (median age: 12.2 years; interquartile range: 10.3-14.9) were included, of whom 78 (14.1%) presented with gingival recession on permanent mandibular incisors and/or localized aggressive periodontitis of molar teeth. Multivariable logistic regression revealed that patients with gingival recession and aggressive periodontitis had a significantly shorter duration of ART and were more likely to have suboptimal HIV control (CD4 count <= 500 cells/mu L and/or HIV viral load >= 50 copies/mL) and be on advanced ART regimens after virologic failure on first- and second-line treatment. Conclusions: The results emphasize the importance of oral health care among HIV-infected children and adolescents from the onset, to prevent and manage conditions that could result in tooth loss and permanent disfigurement. This is of particular importance in the presence of virologic failure and immunosuppression.
引用
收藏
页码:E112 / E115
页数:4
相关论文
共 50 条
  • [31] Adherence to antiretroviral therapy, stigma and behavioral risk factors in HIV-infected adolescents in Asia
    Prasitsuebsai, Wasana
    Sethaputra, Chuenkamol
    Lumbiganon, Pagakrong
    Hansudewechakul, Rawiwan
    Chokephaibulkit, Kulkanya
    Khanh Huu Truong
    Lam Van Nguyen
    Razali, Kamarul Azahar Mohd
    Yusoff, Nik Khairulddin Nik
    Fong, Moy Siew
    Teeraananchai, Sirinya
    Ananworanich, Jintanat
    Durier, Nicolas
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2018, 30 (06): : 727 - 733
  • [32] Lipodystrophy syndrome and cardiovascular risk factors in children and adolescents infected with HIV/AIDS receiving highly active antiretroviral therapy
    Werner, Maria L. F.
    Pone, Marcos V. da S.
    Fonseca, Vania M.
    Chaves, Celia R. M. de M.
    JORNAL DE PEDIATRIA, 2010, 86 (01) : 27 - 32
  • [33] Nutritional status changes in HIV-infected children receiving combined antiretroviral therapy including protease inhibitors
    Fiore, P
    Donelli, E
    Boni, S
    Pontali, E
    Tramalloni, R
    Bassetti, D
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 16 (03) : 365 - 369
  • [34] Dyslipidemia in HIV Infected Children Receiving Highly Active Antiretroviral Therapy
    Anirban Mandal
    Aparna Mukherjee
    R. Lakshmy
    Sushil K. Kabra
    Rakesh Lodha
    The Indian Journal of Pediatrics, 2016, 83 : 226 - 231
  • [35] Lung function in HIV-infected children and adolescents
    Githinji, Leah N.
    Gray, Diane M.
    Zar, Heather J.
    PNEUMONIA, 2018, 10
  • [36] Dyslipidemia in HIV Infected Children Receiving Highly Active Antiretroviral Therapy
    Mandal, Anirban
    Mukherjee, Aparna
    Lakshmy, R.
    Kabra, Sushil K.
    Lodha, Rakesh
    INDIAN JOURNAL OF PEDIATRICS, 2016, 83 (03) : 226 - 231
  • [37] Lung function in HIV-infected children and adolescents
    Leah N. Githinji
    Diane M. Gray
    Heather J. Zar
    Pneumonia, 10 (1)
  • [38] Growth Recovery Among HIV-infected Children Randomized to Lopinavir/Ritonavir or NNRTI-based Antiretroviral Therapy
    Achan, Jane
    Kakuru, Abel
    Ikilezi, Gloria
    Mwangwa, Florence
    Plenty, Albert
    Charlebois, Edwin
    Young, Sera
    Havlir, Diane
    Kamya, Moses
    Ruel, Theodore
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2016, 35 (12) : 1329 - 1332
  • [39] Renal dysfunction among HIV-infected patients starting antiretroviral therapy
    Msango, Leonard
    Downs, Jennifer A.
    Kalluvya, Samuel E.
    Kidenya, Benson R.
    Kabangila, Rodrick
    Johnson, Warren D., Jr.
    Fitzgerald, Daniel W.
    Peck, Robert N.
    AIDS, 2011, 25 (11) : 1421 - 1425
  • [40] Viral load in HIV-infected children on high activity antiretroviral therapy
    Resino, Salvador
    Bellon, Jose M.
    Antonio Leon, Juan
    Resino, Rosa
    Munoz-Fernandez, M. Angeles
    MEDICINA CLINICA, 2007, 128 (02): : 49 - 51